TY - JOUR
T1 - A Comparison of 2‐Hydroxyestradiol and U‐0521 (3′4′‐Dihydroxy‐2‐methylpropiophenone, Upjohn) as In Situ and In Vitro Inhibitors of Tyro sine Hydroxylase
AU - Lloyd, Tom
AU - Boyd, Brenda
AU - Walega, Michael A.
AU - Ebersole, Barbara Jones
AU - Weisz, Judith
PY - 1982/4
Y1 - 1982/4
N2 - Abstract: Feedback inhibition of tyrosine hydroxylase by catechols was evaluated using in situ and in vitro enzyme assays. The three catechol compounds used were norepinephrine, 2‐hydroxyestradiol, and 3′4′‐dihydroxy‐2‐methylpropiophenone (U‐0521, Upjohn); representing endogenous catechol‐amines, catechol estrogens, and a synthetic catechol, respectively. The in situ experiments were performed with dissociated retinal cells from rats and with stationary phase adrenergic‐like neuroblastoma cells (N1E‐115). The catechol estrogen, 2‐hydroxyestradiol, resembled the endogenous catecholamines in its potency to inhibit in vitro and in situ tyrosine hydroxylations with IC50 values of 10 μM in vitro and 100 μM in situ. The drug U‐0521, which has been used as an inhibitor of catechol‐O‐methyltransferase (COMT), was also found to be an inhibitor of tyrosine hydroxylase. Further, it was shown to be more potent than the natural catechols, both in vitro and in situ, with IC50 values of 30–600 nM.
AB - Abstract: Feedback inhibition of tyrosine hydroxylase by catechols was evaluated using in situ and in vitro enzyme assays. The three catechol compounds used were norepinephrine, 2‐hydroxyestradiol, and 3′4′‐dihydroxy‐2‐methylpropiophenone (U‐0521, Upjohn); representing endogenous catechol‐amines, catechol estrogens, and a synthetic catechol, respectively. The in situ experiments were performed with dissociated retinal cells from rats and with stationary phase adrenergic‐like neuroblastoma cells (N1E‐115). The catechol estrogen, 2‐hydroxyestradiol, resembled the endogenous catecholamines in its potency to inhibit in vitro and in situ tyrosine hydroxylations with IC50 values of 10 μM in vitro and 100 μM in situ. The drug U‐0521, which has been used as an inhibitor of catechol‐O‐methyltransferase (COMT), was also found to be an inhibitor of tyrosine hydroxylase. Further, it was shown to be more potent than the natural catechols, both in vitro and in situ, with IC50 values of 30–600 nM.
UR - http://www.scopus.com/inward/record.url?scp=0020471370&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020471370&partnerID=8YFLogxK
U2 - 10.1111/j.1471-4159.1982.tb05334.x
DO - 10.1111/j.1471-4159.1982.tb05334.x
M3 - Article
C2 - 6121005
AN - SCOPUS:0020471370
SN - 0022-3042
VL - 38
SP - 948
EP - 954
JO - Journal of neurochemistry
JF - Journal of neurochemistry
IS - 4
ER -